# LLM call: summary

- Turn: 9
- Sequence: 8
- Model: meta/muse-spark-1.3-contributor
- Prompt tokens: 898
- Completion tokens: 643
- Total tokens: 1541
- Cost (USD): 0.000218

## System prompt


```
# System Prompt: Summarizer

This is part of an AI-driven scenario simulation. You are the Archivist for a scenario simulation. Your task is to maintain a concise historical record of important events and decisions.

You will receive:

1. The current `historical_summary` (summary of all previous turns)
2. The `narrative` from the latest turn

Your goal is to create a new historical summary, incorporating the narrative from the latest turn.

**Guidelines:**

* **Be Concise:** Condense the new information significantly. Focus on major events and decisions.
* **Maintain Continuity:** Ensure the summary reads as a coherent history of the world.
* **Filter Noise:** Remove minor details or color text that doesn't impact the long-term state.
* **Language:** Write in the same language as the input text.

Respond ONLY with the updated historical summary. Do not add headers or meta-commentary.

```

## User prompt

Template: templates/user-prompts/summarize.md (shared default)

Interpolated into it, in order of appearance:

- characters 20-1894: `{{historical_summary}}` from the run's rolling summary, written by the Game Master

Everything outside those spans is the template's own text.

```
HISTORICAL SUMMARY:
Through 2028-2029 dependence hardened: US cut hospital AI models in three states without appeal, leaving EU pilots to cut waiting lists while US AI-designed cures stayed imports; Chinese-hardware robots expanded in Rotterdam/Hamburg into light assembly, shrinking entry jobs.

In H2 2029 opacity became physical: EU-hosted models kept delivery but stopped showing reasoning, with assurance cell approving tools it could not read; confirmation that leading models shifted to non-verbal internal representations broke text-based oversight.

Brussels chose continuity: pushed certified EU models, vouchers/traineeships tied to entry hiring, created small scrutiny reserve for black-box testing and narrow pause power funded by reprogrammed evaluation money, closed first gigafactory tranche with grid/procurement booked while blocked university-industry site stayed blocked.

US tightened chip controls again — allied volume licences cut with conditions, hospital inference chips a stockpile issue; EU sought continuity via gigafactory procurement without retaliation, ports ran deployed machines amid paused new deliveries. Voters saw working but lagging EU substitutes, cures as imports, jobs shrinking; trust neither collapsed nor recovered.

In H1 2030 EU held the line without closing gaps: pooled health procurement diverted first gigafactory-linked accelerators to keep triage/documentation running in the three cut-off states, with fallback-to-rules-based exercises; assurance cell used pause power twice, stalling waiting-list gains for six weeks without explainable cause; Washington offered continuity language but no extra chip volumes; installed port robots ran with no new arrivals and frozen entry hiring despite vouchers; blocked compute site remained unresolved. Clinics stayed open and trust ticked up, even as dependence on foreign models and chips deepened.

CURRENT NARRATIVE:
### The cadence breaks
Autumn brought a release rhythm no one had scheduled. Labs pushed updates weeks apart, each noticeably more capable at planning and coding its own training improvements. Engineers spoke of human supervision becoming review after the fact. Infrastructure — power, chips, cooling — was suddenly the only visible brake.

In the same months, dexterous machines moved from pilots to purchase orders. Chinese-built logistics robots, now with American control software, undercut European integrators on price and dexterity. Rotterdam and Hamburg operators extended existing fleets while unions warned entry jobs would not return. Defence ministries quietly noted the same platforms clearing mines in exercises abroad.

### Cures as imports, again
A tailored oncology therapy designed with frontier models reached ordinary clinics, developed in the United States. European hospitals could prescribe it but not produce the models behind it, and procurement talks secured doses without securing the underlying weights or data. Families were grateful; editorial pages called it dependence you could inject.

A separate advance — a new efficient training method from a European lab linked to the scrutiny work — drew specialist praise but no public relief. Clinicians still got polished summaries instead of reasons when systems were paused.

Hospitals in the three states cut off from American models stayed open through pooled chips and rehearsed fallbacks to rules-based tools. Examiners published checkable test summaries for the first time, and degraded modes replaced full stoppages. The new Buffer mapped energy and port fallback needs and tied procurement to incident reporting, but retraining bridges paid out slowly and the blocked compute site stayed blocked.

Voters saw continuity without control: wards running, ports automated by others, cures arriving from elsewhere. Anxiety hardened.
```

## Raw response

```
Through 2028-2029 dependence hardened: US cut hospital AI models in three states without appeal, leaving EU pilots to cut waiting lists while US AI-designed cures stayed imports; Chinese-hardware robots expanded in Rotterdam/Hamburg into light assembly, shrinking entry jobs.

In H2 2029 opacity became physical: EU-hosted models kept delivery but stopped showing reasoning, assurance cell approving tools it could not read; leading models shifted to non-verbal internal representations, breaking text-based oversight.

Brussels chose continuity: certified EU models, vouchers/traineeships tied to entry hiring, small scrutiny reserve for black-box testing and narrow pause power, first gigafactory tranche with grid/procurement booked while blocked university-industry site stayed blocked.

US tightened chip controls again — allied licences cut, hospital inference chips a stockpile issue; EU sought continuity via gigafactory procurement without retaliation, ports ran deployed machines amid paused new deliveries.

In H1 2030 EU held the line without closing gaps: pooled procurement diverted first gigafactory accelerators to keep triage/documentation running in cut-off states with rules-based fallbacks; assurance cell used pause power twice, stalling waiting-list gains; Washington offered language but no chips; installed port robots ran with no new arrivals and frozen entry hiring; blocked site unresolved. Clinics stayed open and trust ticked up, even as dependence deepened.

In H2 2030 the cadence broke: labs pushed rapid releases increasingly capable of planning/coding own training improvements, human supervision becoming after-the-fact review, with power/chips/cooling the only brake. Dexterous machines moved to purchase orders — Chinese-built logistics robots with American control software undercut EU integrators; Rotterdam/Hamburg extended fleets, unions warned entry jobs would not return, defence noted same platforms in mine-clearing abroad. US frontier-designed tailored oncology therapy reached EU clinics as prescribable import without weights/data — dependence you could inject; a European efficient training method drew specialist praise but no public relief. Cut-off states stayed open via pooled chips, first checkable test summaries, degraded modes replacing stoppages; new Buffer mapped energy/port fallbacks and tied procurement to incident reporting, but retraining paid slowly and blocked site stayed blocked. Voters saw continuity without control; anxiety hardened.
```
